CO4970742A1 - Suspension farmaceutica que comprende hemihidrato de nevipa- rina - Google Patents
Suspension farmaceutica que comprende hemihidrato de nevipa- rinaInfo
- Publication number
- CO4970742A1 CO4970742A1 CO98048247A CO98048247A CO4970742A1 CO 4970742 A1 CO4970742 A1 CO 4970742A1 CO 98048247 A CO98048247 A CO 98048247A CO 98048247 A CO98048247 A CO 98048247A CO 4970742 A1 CO4970742 A1 CO 4970742A1
- Authority
- CO
- Colombia
- Prior art keywords
- nevirapine
- hemihydrate
- nevipa
- rina
- microns
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un método para preparar una suspensión acuosa de nevirapina,cuyo método comprende mezclar hemihidrato de nevirapina que tiene un tamaño de partículas entre 1 y 150 micrómetros, con agua. Una composición farmacéutica, que consta esencialmente de hemihidrato de nevirapina que tiene un tamaño de partículas entre 1 y 150 micrómetros, y agua. Una composición farmacéutica, que consiste esencialmente en los siguientes constituyentes en las cantidades del intervalo relativo especificado.en donde el tamaño de las partículas de nevirapina está entre 1 y 150 micrómetros de diámetro. Una composición farmacéutica de acuerdo con la reivindicación 3, que consta esencialmente de los siguientes constituyentes en las cantidades relativas especificadas. en donde el tamaño de las partículas de nevirapina está entre 1 y 150 micrómetros de diámetro.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5680397P | 1997-08-25 | 1997-08-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4970742A1 true CO4970742A1 (es) | 2000-11-07 |
Family
ID=22006658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98048247A CO4970742A1 (es) | 1997-08-25 | 1998-08-24 | Suspension farmaceutica que comprende hemihidrato de nevipa- rina |
Country Status (38)
| Country | Link |
|---|---|
| US (2) | US6172059B1 (es) |
| EP (1) | EP1019058B1 (es) |
| JP (1) | JP3472261B2 (es) |
| KR (1) | KR100426516B1 (es) |
| CN (1) | CN1197578C (es) |
| AR (2) | AR016869A1 (es) |
| AT (1) | ATE326971T1 (es) |
| AU (1) | AU742761B2 (es) |
| BG (1) | BG64337B1 (es) |
| BR (1) | BR9811994B1 (es) |
| CA (1) | CA2301646C (es) |
| CL (1) | CL2008003111A1 (es) |
| CO (1) | CO4970742A1 (es) |
| CY (1) | CY1105228T1 (es) |
| CZ (1) | CZ290667B6 (es) |
| DE (1) | DE69834655T2 (es) |
| DK (1) | DK1019058T3 (es) |
| EG (1) | EG24075A (es) |
| ES (1) | ES2265666T3 (es) |
| HK (1) | HK1027975A1 (es) |
| HR (1) | HRP980461B1 (es) |
| HU (1) | HU226063B1 (es) |
| ID (1) | ID21650A (es) |
| IL (1) | IL134185A (es) |
| MY (1) | MY122272A (es) |
| NO (1) | NO326226B1 (es) |
| NZ (1) | NZ503414A (es) |
| PE (1) | PE105799A1 (es) |
| PL (1) | PL192361B1 (es) |
| PT (1) | PT1019058E (es) |
| RS (1) | RS49808B (es) |
| RU (1) | RU2196584C2 (es) |
| SA (1) | SA98190680B1 (es) |
| TR (1) | TR200000490T2 (es) |
| TW (1) | TW450812B (es) |
| UA (1) | UA44370C2 (es) |
| WO (1) | WO1999009990A1 (es) |
| ZA (1) | ZA987623B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002092095A1 (en) * | 2001-05-11 | 2002-11-21 | Boehringer Ingelheim International Gmbh | Use of nevirapine to treat or prevent lipid pathology in patients with hiv that is resistant to nevirapine |
| AU2003225108A1 (en) * | 2002-04-23 | 2003-11-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for reduction of residual organic solvent in carbomer |
| BRPI0617074A2 (pt) * | 2005-08-31 | 2011-07-12 | Cipla Ltd | composição farmacêutica, uso de lamivudina, nevirapina e stavudina, uso de stavudina, lamivudina e nevirapina, método para tratar uma infecção viral em um humano, método para preparar uma composição farmacêutica, método para preparar uma forma de dosagem unitária farmacêutica bicamadas e método para preparar uma forma de dosagem unitária farmacêutica tri-camadas |
| US20110082161A1 (en) * | 2008-06-30 | 2011-04-07 | Lieven Elvire Colette Baert | Powders for reconstitution |
| CA2781014C (en) * | 2009-11-10 | 2018-07-31 | Wilna Liebenberg | Method for increasing the solubility of a transcriptase inhibitor composition |
| WO2011073907A1 (en) * | 2009-12-17 | 2011-06-23 | North-West University | A polymorph form of nevirapine and its preparation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5366972A (en) * | 1989-04-20 | 1994-11-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection |
| CA2030056C (en) * | 1989-11-17 | 1995-10-17 | Karl D. Hargrave | 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection |
| US5571912A (en) * | 1990-10-19 | 1996-11-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the preparation of 5,11-dihydro-6h-dipyrido [3,2-b:2',3'-e][1,4]diazepines |
| DE4403311C1 (de) * | 1994-02-03 | 1995-04-20 | Boehringer Ingelheim Kg | Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on) |
-
1998
- 1998-08-11 US US09/131,829 patent/US6172059B1/en not_active Expired - Lifetime
- 1998-08-11 BR BRPI9811994-0B1A patent/BR9811994B1/pt not_active IP Right Cessation
- 1998-08-11 HU HU0003093A patent/HU226063B1/hu not_active IP Right Cessation
- 1998-08-11 PL PL338828A patent/PL192361B1/pl unknown
- 1998-08-11 PE PE1998000718A patent/PE105799A1/es not_active Application Discontinuation
- 1998-08-11 DK DK98939312T patent/DK1019058T3/da active
- 1998-08-11 CA CA002301646A patent/CA2301646C/en not_active Expired - Fee Related
- 1998-08-11 DE DE69834655T patent/DE69834655T2/de not_active Expired - Lifetime
- 1998-08-11 AT AT98939312T patent/ATE326971T1/de active
- 1998-08-11 PT PT98939312T patent/PT1019058E/pt unknown
- 1998-08-11 NZ NZ503414A patent/NZ503414A/xx not_active IP Right Cessation
- 1998-08-11 IL IL13418598A patent/IL134185A/xx not_active IP Right Cessation
- 1998-08-11 JP JP2000507380A patent/JP3472261B2/ja not_active Expired - Fee Related
- 1998-08-11 CN CNB988084899A patent/CN1197578C/zh not_active Expired - Fee Related
- 1998-08-11 KR KR10-2000-7001889A patent/KR100426516B1/ko not_active IP Right Cessation
- 1998-08-11 WO PCT/US1998/016581 patent/WO1999009990A1/en active IP Right Grant
- 1998-08-11 TR TR2000/00490T patent/TR200000490T2/xx unknown
- 1998-08-11 EP EP98939312A patent/EP1019058B1/en not_active Expired - Lifetime
- 1998-08-11 AU AU87771/98A patent/AU742761B2/en not_active Ceased
- 1998-08-11 UA UA2000031668A patent/UA44370C2/uk unknown
- 1998-08-11 RS YUP-98/00A patent/RS49808B/sr unknown
- 1998-08-11 CZ CZ2000694A patent/CZ290667B6/cs not_active IP Right Cessation
- 1998-08-11 RU RU2000107825/14A patent/RU2196584C2/ru not_active IP Right Cessation
- 1998-08-11 ES ES98939312T patent/ES2265666T3/es not_active Expired - Lifetime
- 1998-08-21 MY MYPI98003819A patent/MY122272A/en unknown
- 1998-08-23 EG EG98398A patent/EG24075A/xx active
- 1998-08-24 CO CO98048247A patent/CO4970742A1/es unknown
- 1998-08-24 ID IDP981156A patent/ID21650A/id unknown
- 1998-08-24 HR HR980461A patent/HRP980461B1/xx not_active IP Right Cessation
- 1998-08-24 TW TW087113878A patent/TW450812B/zh not_active IP Right Cessation
- 1998-08-24 ZA ZA9807623A patent/ZA987623B/xx unknown
- 1998-08-25 AR ARP980104200A patent/AR016869A1/es not_active Ceased/Invalidation/Refusal/Rejection/Nullification
- 1998-11-01 SA SA98190680A patent/SA98190680B1/ar unknown
-
2000
- 2000-02-07 BG BG104133A patent/BG64337B1/bg active Active
- 2000-02-24 NO NO20000906A patent/NO326226B1/no not_active IP Right Cessation
- 2000-03-02 US US09/517,564 patent/US6255481B1/en not_active Expired - Lifetime
- 2000-11-20 HK HK00107393A patent/HK1027975A1/xx not_active IP Right Cessation
-
2006
- 2006-08-11 CY CY20061101147T patent/CY1105228T1/el unknown
-
2008
- 2008-10-21 CL CL2008003111A patent/CL2008003111A1/es unknown
-
2011
- 2011-10-14 AR ARP110103815A patent/AR083451A2/es active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0214264B8 (pt) | composição, processos para sua preparação e usos de uma composição | |
| DE3579069D1 (de) | Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung. | |
| ES2177022T3 (es) | Un itraconazol que exhibe una solubilidad mejorada, un metodo para preparar el mismo y una composicion farmaceutica para administracion oral que comprende el mismo. | |
| BR9909394A (pt) | Composição de aerossol, composição farmacêutica, recipiente, dispositivo de inalação, processo para preparar uma composição de aerossol, mistura de um primeiro material particulado, e, processo para administrar um medicamento particulado | |
| IT1296914B1 (it) | Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera | |
| BR9713734A (pt) | Derivados de sulfonamidas, processo para sua preparação, e seu uso como medicamentos | |
| AR017079A1 (es) | Una composicion farmaceutica, un procedimiento para la preparacion de la misma, un metodo de tratamiento y su uso. | |
| MX9305273A (es) | Suspensiones acuosas de particulas coloidales, preparacion y uso de las mismas. | |
| ES2106857T3 (es) | Mejoras en o relacionadas con agentes de contraste. | |
| ES2060104T3 (es) | Gel acuoso que contiene en suspension unos esferoides de una substancia lipidica solida no hidrofila. | |
| UY26370A1 (es) | "imidazo-5-il-aminas bicíclicas, medicamentos que las contienen, su uso para la preparación de medicamentos y procedimiento para su preparación". | |
| ES525794A0 (es) | Procedimiento para la preparacion de un granulado de polimero | |
| BR0109802A (pt) | Preparações farmacêuticas e sua fabricação | |
| CO4970742A1 (es) | Suspension farmaceutica que comprende hemihidrato de nevipa- rina | |
| ATE297223T1 (de) | Teilchenförmige vitaminzubereitung | |
| ES2071905T3 (es) | Dispersiones de copolimeros de bloques y procedimiento para preparar dispersiones de copolimeros de bloques. | |
| BR9900457A (pt) | Liga de alumìnio e bismuto, mancal de deslizamento contendo a mesma e método para prepará-la | |
| MX166629B (es) | Composicion de revestimiento liquida pigmentada y metodo para formarla | |
| ECSP941120A (es) | Derivados de 1,5 benzodiazepina | |
| AR026539A1 (es) | Composicion de gel aireado con estabilidad de almacenamiento y un proceso para su elaboracion | |
| ES2032470T3 (es) | Una emulsion de aceite en agua. | |
| ES2062145T3 (es) | 1,8-naftiridinas substituidas. | |
| RS50345B (sr) | Vodena farmaceutska kompozicija koja sadrži ciklesonid | |
| KR860003825A (ko) | 안정한 현탁액 제조용 고체 약물제형의 제조방법 | |
| BR0110881A (pt) | Processo para a preparação de corpos sólidos inorg nicos porosos a partir de uma dispersão aquosa de partìculas, corpos sólidos inorg nicos porosos, e, uso de corpos sólidos inorg nicos porosos |